FDA approves extended-release, single-entity hydrocodone product

The U.S. Food and Drug Administration today approved Zohydro ER (hydrocodone bitartrate extended-release capsules) for the management of pain severe enough to require daily, around-the-clock, long-term treatment and for which alternative treatment options are inadequate.

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm372287.htm

Source: Food and Drug Administration - October 25, 2013 Category: American Health Source Type: news

More News: American Health | Food and Drug Administration (FDA) | Hydrocodone | Pain | Pain Management